HOSTED PROTOTYPE

Use synthetic data only. No prescriptions are issued or medications dispensed.

PoeRx
HomeCompareOzempic vs. Mounjaro
Weight management & diabetes

Compare Ozempic vs. Mounjaro

Compare two prescription products commonly discussed for type 2 diabetes: semaglutide and tirzepatide.

MEDICAL REVIEW REQUIREDFDA and DailyMed labeling · editorial prototype

Key takeaways

  • Ozempic contains semaglutide; Mounjaro contains tirzepatide.
  • Both are used in eligible patients with type 2 diabetes, but they are different products with different labeling.
  • A prescriber should compare the complete medical history, current medicines, goals, risks, and access before making a treatment decision.

How they compare

EDITORIAL GUIDE
TopicOzempicsemaglutideMounjarotirzepatide
Active ingredientSemaglutideTirzepatide
Medication classGLP-1 receptor agonistGIP/GLP-1 receptor agonist
Common FDA-approved focusType 2 diabetes management for eligible patientsType 2 diabetes management for eligible patients
AccessPrescription requiredPrescription required
DecisionRequires an individual clinician reviewRequires an individual clinician review

Primary sources

Labeling can change. Use the current FDA prescribing information and speak with a licensed clinician or pharmacist before making a treatment decision.

Ozempic FDA label Mounjaro FDA label